Overview
- L’Oréal is acquiring the additional stake from Sunshine SwissCo, a consortium led by EQT with ADIA and Auba Investment.
- Financial terms were not disclosed, and L’Oréal will fund the purchase with available cash and credit lines.
- Galderma’s board will consider nominating two non-independent L’Oréal directors to replace consortium representatives at the 2026 annual meeting.
- Both companies indicated plans to expand scientific collaboration in dermatology under CEO Flemming Ørnskov.
- L’Oréal said it supports Galderma’s strategy and independence and is not planning further increases, building on its initial 10% purchase in August 2024.